Cardiovascular Disease and Breast Cancer: Where These Entities Intersect A Scientific Statement From the American Heart Association

被引:556
作者
Mehta, Laxmi S.
Watson, Karol E.
Barac, Ana
Beckie, Theresa M.
Bittner, Vera
Cruz-Flores, Salvador
Dent, Susan
Kondapalli, Lavanya
Ky, Bonnie
Okwuosa, Tochukwu
Pina, Ileana L.
Volgman, Annabelle Santos
机构
关键词
AHA Scientific Statement; breast cancer; cardiotoxicity; cardiovascular disease; oncology; prevention; risk factors; CONVERTING ENZYME-INHIBITORS; LEFT-VENTRICULAR DYSFUNCTION; ADJUVANT ENDOCRINE THERAPY; DEPENDENT KINASE 4/6; ALL-CAUSE MORTALITY; BODY-MASS INDEX; ANTHRACYCLINE-INDUCED CARDIOTOXICITY; TRASTUZUMAB-RELATED CARDIOTOXICITY; DOXORUBICIN-INDUCED CARDIOMYOPATHY; MODERATE ALCOHOL-CONSUMPTION;
D O I
10.1161/CIR.0000000000000556
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Cardiovascular disease (CVD) remains the leading cause of mortality in women, yet many people perceive breast cancer to be the number one threat to women's health. CVD and breast cancer have several overlapping risk factors, such as obesity and smoking. Additionally, current breast cancer treatments can have a negative impact on cardiovascular health (eg, left ventricular dysfunction, accelerated CVD), and for women with pre-existing CVD, this might influence cancer treatment decisions by both the patient and the provider. Improvements in early detection and treatment of breast cancer have led to an increasing number of breast cancer survivors who are at risk of long-term cardiac complications from cancer treatments. For older women, CVD poses a greater mortality threat than breast cancer itself. This is the first scientific statement from the American Heart Association on CVD and breast cancer. This document will provide a comprehensive overview of the prevalence of these diseases, shared risk factors, the cardiotoxic effects of therapy, and the prevention and treatment of CVD in breast cancer patients.
引用
收藏
页码:E30 / E66
页数:37
相关论文
共 405 条
  • [1] Abe O, 2005, LANCET, V366, P2087, DOI 10.1016/s0140-6736(05)66544-0
  • [2] Dietary patterns and the risk of breast cancer
    Adebamowo, CA
    Hu, FB
    Cho, E
    Spiegelman, D
    Holmes, MD
    Willett, WC
    [J]. ANNALS OF EPIDEMIOLOGY, 2005, 15 (10) : 789 - 795
  • [3] Statin Prescriptions and Breast Cancer Recurrence Risk: A Danish Nationwide Prospective Cohort Study
    Ahern, Thomas P.
    Pedersen, Lars
    Tarp, Maja
    Cronin-Fenton, Deirdre P.
    Garne, Jens Peter
    Silliman, Rebecca A.
    Sorensen, Henrik Toft
    Lash, Timothy L.
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2011, 103 (19): : 1461 - 1468
  • [4] 2011 Compendium of Physical Activities: A Second Update of Codes and MET Values
    Ainsworth, Barbara E.
    Haskell, William L.
    Herrmann, Stephen D.
    Meckes, Nathanael
    Bassett, David R., Jr.
    Tudor-Locke, Catrine
    Greer, Jennifer L.
    Vezina, Jesse
    Whitt-Glover, Melicia C.
    Leon, Arthur S.
    [J]. MEDICINE AND SCIENCE IN SPORTS AND EXERCISE, 2011, 43 (08) : 1575 - 1581
  • [5] AKHTAR SS, 1993, ONCOLOGY, V50, P441
  • [6] Protective effects of spironolactone against anthracycline-induced cardiomyopathy
    Akpek, Mahmut
    Ozdogru, Ibrahim
    Sahin, Omer
    Inanc, Mevlude
    Dogan, Ali
    Yazici, Cevat
    Berk, Veli
    Karaca, Halit
    Kalay, Nihat
    Oguzhan, Abdurrahman
    Ergin, Ali
    [J]. EUROPEAN JOURNAL OF HEART FAILURE, 2015, 17 (01) : 81 - 89
  • [7] A review and meta-analysis of red and processed meat consumption and breast cancer
    Alexander, Dominik D.
    Morimoto, Libby M.
    Mink, Pamela J.
    Cushing, Colleen A.
    [J]. NUTRITION RESEARCH REVIEWS, 2010, 23 (02) : 349 - 365
  • [8] Alter P., 2006, Cardiovascular & Hematological Agents in Medicinal Chemistry, V4, P1, DOI 10.2174/187152506775268785
  • [9] Recurrent asymptomatic bradycardia episodes after cisplatin infusion
    Altundag, Ö
    Çelik, I
    Kars, A
    [J]. ANNALS OF PHARMACOTHERAPY, 2001, 35 (05) : 641 - 642
  • [10] Overweight, obesity and risk of premenopausal breast cancer according to ethnicity: a systematic review and dose-response meta-analysis
    Amadou, A.
    Ferrari, P.
    Muwonge, R.
    Moskal, A.
    Biessy, C.
    Romieu, I.
    Hainaut, P.
    [J]. OBESITY REVIEWS, 2013, 14 (08) : 665 - 678